SPHINX31 is primarily utilized in neuropharmacological research to study the mechanisms of action of compounds affecting the central nervous system, particularly in enhancing memory and learning. It is also investigated for its potential in treating neurodegenerative diseases such as Alzheimer's and Parkinson's, due to its ability to inhibit enzymes involved in neuronal cell degeneration. Additionally, SPHINX31 is tested in animal models to evaluate its efficacy and safety prior to potential human applications, serving as a valuable tool in drug discovery and biochemical studies of cellular signaling pathways related to neurological functions.